Mohsen Rokni

Cytokines and COVID-19: friends or foes?

Mohsen Rokni, Michael R. Hamblin, Nima Rezaei · Human Vaccines & Immunotherapeutics · 2020 · 79 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness

Mohsen Rokni, Kazem Ahmadikia, Somaye Asghari et al. · BMC Infectious Diseases · 2020 · 55 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17

Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses

Mohsen Rokni, Milad Heidari Nia, Mohammad Sarhadi et al. · Applied Biochemistry and Biotechnology · 2022 · 53 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Association of polymorphisms in tumor necrosis factors with SARS‐CoV‐2 infection and mortality rate: A case‐control study and in silico analyses

Milad Heidari Nia, Mohsen Rokni, Shekoufeh Mirinejad et al. · Journal of Medical Virology · 2021 · 43 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Single nucleotide polymorphisms located in <i>TNFA, IL1RN, IL6R</i>, and <i>IL6</i> genes are associated with COVID‐19 risk and severity in an Iranian population

Mohsen Rokni, Mohammad Sarhadi, Milad Heidari Nia et al. · Cell Biology International · 2022 · 33 citations · Full text

Life Sciences, Genetics, Immunology +17